Senti Biosciences Holdings, Inc.
SNTI
$0.30
-$0.02-5.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -49.56M | -51.55M | -61.44M | -47.58M | -58.32M |
| Total Depreciation and Amortization | 3.15M | 3.40M | 3.64M | 3.68M | 3.72M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.71M | 4.20M | 10.80M | -8.50M | 6.42M |
| Change in Net Operating Assets | 4.65M | 7.07M | 3.56M | 2.33M | -318.00K |
| Cash from Operations | -38.05M | -36.88M | -43.44M | -50.07M | -48.49M |
| Capital Expenditure | 0.00 | -196.00K | -196.00K | -207.00K | -207.00K |
| Sale of Property, Plant, and Equipment | 114.00K | 126.00K | 12.00K | 12.00K | 72.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 114.00K | -70.00K | -184.00K | -195.00K | -135.00K |
| Total Debt Issued | 9.70M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 10.65M | 11.18M | 11.18M | 49.72M | 49.59M |
| Repurchase of Common Stock | -118.00K | -118.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 493.00K | 995.00K | 581.00K | 2.29M | 4.73M |
| Cash from Financing | 20.72M | 12.06M | 11.76M | 52.01M | 54.33M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.22M | -24.89M | -31.87M | 1.74M | 5.70M |